 Well, I'm from Australia, so it was good to try and get an international perspective. The European market is probably one of the largest markets outside of the United States. So it's good to be able to come from outside of a very large, as we would say, drug market and get a greater understanding globally of how things happened. So that was one of the main reasons why I came here, and hopefully I'll be able to take some of the information that I've learnt and be able to take it back to my colleagues so we can understand where we fit in the global perspective.